Working…
COVID-19 is an emerging, rapidly evolving situation.
Get the latest public health information from CDC: https://www.coronavirus.gov.

Get the latest research information from NIH: https://www.nih.gov/coronavirus.
ClinicalTrials.gov
ClinicalTrials.gov Menu

Adapting Tools to Implement Stroke Risk Management to Veterans (TOOLS)

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.
 
ClinicalTrials.gov Identifier: NCT00355147
Recruitment Status : Completed
First Posted : July 21, 2006
Results First Posted : February 10, 2015
Last Update Posted : October 11, 2018
Sponsor:
Collaborator:
Indiana University
Information provided by (Responsible Party):
VA Office of Research and Development

Study Type Interventional
Study Design Allocation: Randomized;   Intervention Model: Parallel Assignment;   Masking: Double (Participant, Outcomes Assessor);   Primary Purpose: Health Services Research
Conditions Ischemic Stroke
Transient Ischemic Attack
Interventions Behavioral: Physician stroke guideline adherence
Behavioral: Stroke Self Management
Other: Attention Control Group
Enrollment 174
Recruitment Details  
Pre-assignment Details  
Arm/Group Title Arm 1 Stroke Prevention Intervention Arm 2 Control Group
Hide Arm/Group Description Randomized to receive the intervention which included receipt of stroke prevention and self management intervention and stroke peer support. Received usual care, follow up telephone calls to control for contact, and educational materials
Period Title: Overall Study
Started 87 87
Completed 69 67
Not Completed 18 20
Reason Not Completed
Lost to Follow-up             10             8
Withdrawal by Subject             8             12
Arm/Group Title Arm 1 Stroke Self Management and Risk Factor Program Attention Control Group Total
Hide Arm/Group Description

Patient Secondary Stroke Risk Factor Program including Stroke Self Management and Stroke Peer Support

Physician stroke guideline adherence: Provided clinicians with Secondary Stroke Prevention Guidelines/Posted near workstations for Discharge Planning and Provided Clinicians with Seminar on Motivational Interviewing and Goal Setting to Modify Patient Health Behaviors

Secondary Stroke Self-Management and Risk Factor Management: Provided Post Stroke Guidelines on Secondary Prevention to Clinicians Preparing Discharge Plans; Provided Secondary Stroke Self-Management and Stroke Peer Support to Veteran Patients with Stroke/Transcient Ischemic Attack

Received Phone Calls from Staff to Control for Attention Total of all reporting groups
Overall Number of Baseline Participants 87 87 174
Hide Baseline Analysis Population Description
Compared groups on strata, age, sex, race/ethnicity, education level, living status, has Caregiver Number of participants were determined by protocol and followed intention to treat. For 3 and 6 month outcomes, we included respondent's last score assuming no change among those with missing data.
Age, Continuous  
Mean (Standard Deviation)
Unit of measure:  Years
Number Analyzed 87 participants 87 participants 174 participants
60.4  (9.5) 62.1  (9.4) 61.3  (9.5)
Sex: Female, Male   [1] 
Measure Type: Count of Participants
Unit of measure:  Participants
Number Analyzed 87 participants 87 participants 174 participants
Female
3
   3.4%
2
   2.3%
5
   2.9%
Male
84
  96.6%
85
  97.7%
169
  97.1%
[1]
Measure Description: Self reported description of respondent's sex
Ethnicity (NIH/OMB)  
Measure Type: Count of Participants
Unit of measure:  Participants
Number Analyzed 87 participants 87 participants 174 participants
Hispanic or Latino
11
  12.6%
4
   4.6%
15
   8.6%
Not Hispanic or Latino
76
  87.4%
83
  95.4%
159
  91.4%
Unknown or Not Reported
0
   0.0%
0
   0.0%
0
   0.0%
Race (NIH/OMB)  
Measure Type: Count of Participants
Unit of measure:  Participants
Number Analyzed 87 participants 87 participants 174 participants
American Indian or Alaska Native
1
   1.1%
1
   1.1%
2
   1.1%
Asian
0
   0.0%
0
   0.0%
0
   0.0%
Native Hawaiian or Other Pacific Islander
0
   0.0%
1
   1.1%
1
   0.6%
Black or African American
24
  27.6%
29
  33.3%
53
  30.5%
White
54
  62.1%
51
  58.6%
105
  60.3%
More than one race
1
   1.1%
0
   0.0%
1
   0.6%
Unknown or Not Reported
7
   8.0%
5
   5.7%
12
   6.9%
Stroke Specific, Health-Related Quality of Life   [1] 
Mean (Standard Deviation)
Unit of measure:  Units on a scale
Number Analyzed 87 participants 87 participants 174 participants
3.72  (0.68) 3.92  (0.72) 3.84  (0.72)
[1]
Measure Description: Stroke, specific, health-related quality of life (SSQoL) is a self-reported survey by LS Williams et al Stroke. 1999;30:1362-1369. Includes 12 domains and 49 items which are scored on a 5pt Likert response format with lower score indicating worse function/lower ability on that item or domain. Domain scores were calculated as an unweighted average of item scores in that domain. Overall Total Score was calculated as an unweighted average of domain scores. Each Domain Score and the Overall Total Score all range from 1-5 with 1 being worst and 5 best best.
Self-Efficacy to Manage Stroke   [1] 
Mean (Standard Deviation)
Unit of measure:  Units on a scale
Number Analyzed 87 participants 87 participants 174 participants
7.72  (1.68) 8.30  (1.60) 8.14  (1.60)
[1]
Measure Description: This scale is modified from the Arthitis Self-Efficacy scale and is designed to measure Confidence to Manage Stroke Symptoms. The items measure the confidence to manage symptoms and health post stroke on a 1-10 scale where 10 denotes a lot of confidence and a 1 denotes no confidence. The scale score is the average score of the items.
Self-Efficacy to Communicate with Physician   [1] 
Mean (Standard Deviation)
Unit of measure:  Units on a scale
Number Analyzed 87 participants 87 participants 174 participants
2.08  (0.96) 2.56  (1.28) 2.32  (1.16)
[1]
Measure Description: The scale designed by K Lorig measures the confidence to communicate with a physician about the patient's health. The response items range from 1-10 where 10 denotes a lot of confidence and a 1 denotes no confidence. The score equals the average of the items.
Stroke Specific Health Related Quality of Life Perceived Energy   [1] 
Mean (Standard Deviation)
Unit of measure:  Units on a scale
Number Analyzed 87 participants 87 participants 174 participants
2.62  (1.24) 3.30  (1.36) 3.04  (1.36)
[1]
Measure Description: Perceived Energy Subdomain of the Stroke Specific Quality of Life measures perceived energy after stroke. Item response is on a 5 point Likert scale where 1 denotes worse functioning and 5 denotes best functioning. Domain score was calculated as an unweighted average of item scores in the Energy subdomain.
Patient Health Questionnaire (PHQ)9 Depressive Symptoms   [1] 
Mean (Standard Deviation)
Unit of measure:  Units on a scale
Number Analyzed 87 participants 87 participants 174 participants
7.72  (6.16) 6.82  (6.68) 7.00  (6.34)
[1]
Measure Description: PHQ9 is a commonly used scale to measure the degree by which a respondent was bothered by depressive symptoms during the past 2 weeks by Spitzer, Williams, and Kroenke. Each of the 9 items use a 0-3 item response where 0 = "not at all" and 3 ="nearly every day." Total score is the sum of the 9 items.
1.Primary Outcome
Title Stroke Specific Health Related Quality of Life
Hide Description
  • Stroke Specifc, Health Related Quality of Life (SSQoL)
  • Self reported survey by LS Williams Weinberger M, Clark, D, Harris L, Biller J. Development of a stroke specific quality of life scale. Stroke, 1999;30:1362-1369.
  • Contains 12 domains and 49 items Scored on a 5 pt Likert response format with lower score indicating worse function/lower ability on that item or domain. Domain scores were calculated as an unweighted average of item scores in that domain. Overall Total Score was calculated as an unweighted average of domain scores.

We hypothesized the intervention group would report significantly greater stroke specific quality of life than the control group. The level of significance was set to 0.05.

Time Frame 6 months for (SSQoL) and 3 months for Perceived Energy Subdomain
Hide Outcome Measure Data
Hide Analysis Population Description
We hypothesized the intervention group would report significantly greater stroke specific quality of life than the control group. The level of significance was set to 0.05. Number of participants were set per protocol and we used intention to treat in our protocol and analyses. We adjusted the analyses for group, TIA/Stroke, site, and time.
Arm/Group Title Arm 1 Stroke Self Management and Risk Factor Program Attention Control Group
Hide Arm/Group Description:

Patient Secondary Stroke Risk Factor Program including Stroke Self Management and Stroke Peer Support

Physician stroke guideline adherence: Provided clinicians with Secondary Stroke Prevention Guidelines/Posted near workstations for Discharge Planning and Provided Clinicians with Seminar on Motivational Interviewing and Goal Setting to Modify Patient Health Behaviors

Secondary Stroke Self-Management and Risk Factor Management: Provided Post Stroke Guidelines on Secondary Prevention to Clinicians Preparing Discharge Plans; Provided Secondary Stroke Self-Management and Stroke Peer Support to Veteran Patients with Stroke/TIA

Received Phone Calls from Staff to Control for Attention
Overall Number of Participants Analyzed 71 68
Mean (Standard Deviation)
Unit of Measure: units on a scale
Overall Total Score 3.80  (0.90) 3.94  (0.82)
Perceived Energy Score 2.98  (1.56) 3.04  (1.42)
Hide Statistical Analysis 1
Statistical Analysis Overview Comparison Group Selection Arm 1 Stroke Self Management and Risk Factor Program, Attention Control Group
Comments This is an analysis of the outcome, Stroke Specific Quality of Life Overall Total Score.
Type of Statistical Test Superiority or Other
Comments [Not Specified]
Statistical Test of Hypothesis P-Value 0.69
Comments [Not Specified]
Method Mixed Models Analysis
Comments Adjusted for site, strata, baseline score, randomized group, month and the group by month interaction
Method of Estimation Estimation Parameter Mean Difference (Net)
Estimated Value 0.05
Parameter Dispersion
Type: Standard Error of the Mean
Value: 0.11
Estimation Comments This score represents change from baseline to six months across the groups.
Hide Statistical Analysis 2
Statistical Analysis Overview Comparison Group Selection Arm 1 Stroke Self Management and Risk Factor Program, Attention Control Group
Comments This is an analysis of the Perceived Energy Domain within the Stroke Specific Quality of Life Measure
Type of Statistical Test Superiority or Other
Comments [Not Specified]
Statistical Test of Hypothesis P-Value 0.05
Comments Adjusted for site, strata, baseline value, treatment group, month of assessment, treatment group x month, random subject effect
Method Mixed Models Analysis
Comments [Not Specified]
Method of Estimation Estimation Parameter Mean Difference (Net)
Estimated Value 0.47
Parameter Dispersion
Type: Standard Error of the Mean
Value: 0.23
Estimation Comments This score represents change from baseline to three months across groups.
2.Primary Outcome
Title Self-Efficacy to Manage Stroke Symptoms
Hide Description Confidence to manage symptoms and health post stroke on a 1-10 scale where 10 denotes a lot of confidence and a 1 denotes no confidence.
Time Frame 6 months
Hide Outcome Measure Data
Hide Analysis Population Description
We hypothesized the intervention group would report significantly greater self-efficacy to manage stroke symptoms than the control group. Level of significance was set to .05. Number of participants were set per protocol and we used intention to treat in our protocol and analyses. We adjusted the analyses for group, TIA/Stroke, site, & time.
Arm/Group Title Arm 1 Stroke Self Management and Risk Factor Program Attention Control Group
Hide Arm/Group Description:

Patient Secondary Stroke Risk Factor Program including Stroke Self Management and Stroke Peer Support

Physician stroke guideline adherence: Provided clinicians with Secondary Stroke Prevention Guidelines/Posted near workstations for Discharge Planning and Provided Clinicians with Seminar on Motivational Interviewing and Goal Setting to Modify Patient Health Behaviors

Secondary Stroke Self-Management and Risk Factor Management: Provided Post Stroke Guidelines on Secondary Prevention to Clinicians Preparing Discharge Plans; Provided Secondary Stroke Self-Management and Stroke Peer Support to Veteran Patients with Stroke/TIA

Received Phone Calls from Staff to Control for Attention
Overall Number of Participants Analyzed 60 63
Mean (Standard Deviation)
Unit of Measure: units on a scale
7.90  (1.78) 8.08  (1.80)
Hide Statistical Analysis 1
Statistical Analysis Overview Comparison Group Selection Arm 1 Stroke Self Management and Risk Factor Program, Attention Control Group
Comments [Not Specified]
Type of Statistical Test Superiority or Other
Comments [Not Specified]
Statistical Test of Hypothesis P-Value 0.66
Comments [Not Specified]
Method Mixed Models Analysis
Comments Adjusted by site, strata, baseline score, treatment group, month and group by month interaction
Method of Estimation Estimation Parameter Mean Difference (Net)
Estimated Value 0.12
Estimation Comments The score is the change from baseline to six months between groups.
3.Secondary Outcome
Title Medication (Diabetes) Compliance for Secondary Stroke Prevention Risk Factor Managment
Hide Description
  • Medication Possession Ratios 6 months post stroke events based upon Pharmacy Refill data
  • Medication Possession Ratios are the % of days in follow up period of 6 months with possession of oral Diabetes drugs (range = 0 -100%)
  • Compliance is defined as Medication Possession Ratio for Diabetes drugs dichotomized as greater than and equal to 80%
Time Frame baseline, 6 months
Hide Outcome Measure Data
Hide Analysis Population Description
We hypothesized the intervention group would report significantly greater medication compliance than the control group. The level of significance was set to 0.05. The number of participants were set per protocol and we used intention to treat in our protocol and analyses.
Arm/Group Title Arm 1 Secondary Risk Factor Management Attention Control Group
Hide Arm/Group Description:

Patient Secondary Stroke Risk Factor Program including Stroke Self Management and Stroke Peer Support and Physician Stroke Guideline Adherence

Physician stroke guideline adherence: Provided clinicians with Secondary Stroke Prevention Guidelines/Posted near workstations for Discharge Planning and Provided Clinicians with Seminar on Motivational Interviewing and Goal Setting to Modify Patient Health Behaviors

Stroke Self Management: Provided Post Stroke Guidelines on Secondary Prevention to Clinicians Preparing Discharge Plans; Provided Secondary Stroke Self-Management and Stroke Peer Support to Veteran Patients with Stroke/TIA

Received Phone Calls from Staff to Control for Attention
Overall Number of Participants Analyzed 32 14
Measure Type: Number
Unit of Measure: participants
>=80% Compliance at baseline 13 8
<80% Compliance at baseline 19 6
>=80% Compliance at 6 months 21 6
<80% Compliance at 6 months 11 8
Hide Statistical Analysis 1
Statistical Analysis Overview Comparison Group Selection Arm 1 Secondary Risk Factor Management, Attention Control Group
Comments [Not Specified]
Type of Statistical Test Superiority or Other
Comments [Not Specified]
Statistical Test of Hypothesis P-Value 0.06
Comments [Not Specified]
Method Regression, Logistic
Comments [Not Specified]
Method of Estimation Estimation Parameter Odds Ratio (OR)
Estimated Value 6.74
Confidence Interval (2-Sided) 95%
0.88 to 51.31
Estimation Comments [Not Specified]
Hide Statistical Analysis 2
Statistical Analysis Overview Comparison Group Selection Arm 1 Secondary Risk Factor Management
Comments Within group Intervention Pre Post Comparison Compliance with Diabetes Medication
Type of Statistical Test Superiority or Other
Comments [Not Specified]
Statistical Test of Hypothesis P-Value 0.036
Comments [Not Specified]
Method Regression, Logistic
Comments [Not Specified]
Method of Estimation Estimation Parameter Odds Ratio (OR)
Estimated Value 3.45
Confidence Interval (2-Sided) 95%
1.08 to 10.96
Estimation Comments [Not Specified]
Hide Statistical Analysis 3
Statistical Analysis Overview Comparison Group Selection Attention Control Group
Comments Within Group attention control group intervention pre post comparison compliance with Diabetes Medication
Type of Statistical Test Superiority or Other
Comments [Not Specified]
Statistical Test of Hypothesis P-Value 0.407
Comments [Not Specified]
Method Regression, Logistic
Comments [Not Specified]
Method of Estimation Estimation Parameter Odds Ratio (OR)
Estimated Value 0.51
Confidence Interval (2-Sided) 95%
0.10 to 2.70
Estimation Comments [Not Specified]
4.Secondary Outcome
Title Medication (Statins) for Secondary Stroke Prevention Risk Factor Management
Hide Description
  • Medication Possession Ratios 6 months post stroke event based upon Pharmacy Refill data
  • Medication Possession Ratios are the % of days in follow up period of 6 months with possession of Statin drugs (range= 0-100%).
  • Compliance is defined as Medication Possession Ratio for Statin drugs dichotomized as greater than and equal to 80%.
Time Frame baseline, 6 months
Hide Outcome Measure Data
Hide Analysis Population Description
We hypothesized the intervention group would report significantly greater medication compliance than the control group. The level of significance was set to 0.05. The number of participants were set per protocol and we used intention to treat in our protocol and analyses.
Arm/Group Title Arm 1 Stroke Prevention Intervention Arm 2 Control Group
Hide Arm/Group Description:
Randomized to receive the intervention which included receipt of stroke prevention and self management intervention and stroke peer support.
Received usual care, follow up telephone calls to control for contact, and educational materials
Overall Number of Participants Analyzed 72 71
Measure Type: Number
Unit of Measure: participants
>=80% Compliance at baseline 16 18
<80% Compliance at baseline 56 53
>=80% Compliance at 6 months 44 39
<80% Compliance at 6 months 28 32
Hide Statistical Analysis 1
Statistical Analysis Overview Comparison Group Selection Arm 1 Stroke Prevention Intervention, Arm 2 Control Group
Comments Between Group Intervention Pre Post Comparison Compliance with Statin Medication
Type of Statistical Test Superiority or Other
Comments [Not Specified]
Statistical Test of Hypothesis P-Value 0.05
Comments [Not Specified]
Method Regression, Logistic
Comments [Not Specified]
Method of Estimation Estimation Parameter Odds Ratio (OR)
Estimated Value 1.56
Confidence Interval (2-Sided) 95%
0.54 to 4.48
Estimation Comments [Not Specified]
Hide Statistical Analysis 2
Statistical Analysis Overview Comparison Group Selection Arm 1 Stroke Prevention Intervention
Comments Within Group Intervention Pre Post Comparison Compliance with Statin Medication
Type of Statistical Test Superiority or Other
Comments [Not Specified]
Statistical Test of Hypothesis P-Value 0.0001
Comments [Not Specified]
Method Regression, Logistic
Comments [Not Specified]
Method of Estimation Estimation Parameter Odds Ratio (OR)
Estimated Value 5.98
Confidence Interval (2-Sided) 95%
2.81 to 12.76
Estimation Comments [Not Specified]
Hide Statistical Analysis 3
Statistical Analysis Overview Comparison Group Selection Arm 2 Control Group
Comments Within Group Attention Control Pre Post Comparison Compliance with Statin Medication.
Type of Statistical Test Superiority or Other
Comments [Not Specified]
Statistical Test of Hypothesis P-Value 0.0004
Comments [Not Specified]
Method Regression, Logistic
Comments [Not Specified]
Method of Estimation Estimation Parameter Odds Ratio (OR)
Estimated Value 3.83
Confidence Interval (2-Sided) 95%
1.83 to 8.01
Estimation Comments [Not Specified]
5.Secondary Outcome
Title Medication (Hypertension) Compliance for Secondary Stroke Prevention Risk Factor Management
Hide Description
  • Medication Possession Ratios 6 months post stroke event based upon Pharmacy Refill data
  • Medication Possession Ratios are the % of days in follow up period of 6 months with possession of hypertension drugs (range = 0-100%)
  • Compliance is defined as Medication Possession Ratio for Hypertension drugs dichotomized as greater than and equal to 80%.
Time Frame Baseline, 6 months
Hide Outcome Measure Data
Hide Analysis Population Description
We hypothesized the intervention group would report significantly greater medication compliance than the control group. The level of significance was set to 0.05. The number of participants were set per protocol and we used intention to treat in our protocol and analyses.
Arm/Group Title Arm 1 Stroke Self Management and Risk Factor Program Attention Control Group
Hide Arm/Group Description:

Patient Secondary Stroke Risk Factor Program including Stroke Self Management and Stroke Peer Support

Physician stroke guideline adherence: Provided clinicians with Secondary Stroke Prevention Guidelines/Posted near workstations for Discharge Planning and Provided Clinicians with Seminar on Motivational Interviewing and Goal Setting to Modify Patient Health Behaviors

Secondary Stroke Self-Management and Risk Factor Management: Provided Post Stroke Guidelines on Secondary Prevention to Clinicians Preparing Discharge Plans; Provided Secondary Stroke Self-Management and Stroke Peer Support to Veteran Patients with Stroke/Transcient Ischemic Attack

Received Phone Calls from Staff to Control for Attention
Overall Number of Participants Analyzed 79 70
Measure Type: Number
Unit of Measure: participants
>=80% Compliance at baseline 39 41
<80% Compliance at baseline 40 29
>=80% Compliance at 6 months 61 48
<80% Compliance at 6 months 18 22
Hide Statistical Analysis 1
Statistical Analysis Overview Comparison Group Selection Arm 1 Stroke Self Management and Risk Factor Program, Attention Control Group
Comments Between Group Intervention Pre Post Comparison Compliance with Hypertension Medication
Type of Statistical Test Superiority or Other
Comments [Not Specified]
Statistical Test of Hypothesis P-Value 0.096
Comments [Not Specified]
Method Regression, Logistic
Comments [Not Specified]
Method of Estimation Estimation Parameter Odds Ratio (OR)
Estimated Value 2.34
Confidence Interval (2-Sided) 95%
0.86 to 6.40
Estimation Comments [Not Specified]
Hide Statistical Analysis 2
Statistical Analysis Overview Comparison Group Selection Arm 1 Stroke Self Management and Risk Factor Program
Comments Within Group Intervention Pre Post Comparison Compliance with Hypertension Medication
Type of Statistical Test Superiority or Other
Comments [Not Specified]
Statistical Test of Hypothesis P-Value 0.0004
Comments [Not Specified]
Method Regression, Logistic
Comments [Not Specified]
Method of Estimation Estimation Parameter Odds Ratio (OR)
Estimated Value 3.68
Confidence Interval (2-Sided) 95%
1.81 to 7.48
Estimation Comments [Not Specified]
Hide Statistical Analysis 3
Statistical Analysis Overview Comparison Group Selection Attention Control Group
Comments Within Group Attention Group Pre Post Comparison Compliance with Hypertension Medication.
Type of Statistical Test Superiority or Other
Comments [Not Specified]
Statistical Test of Hypothesis P-Value 0.21
Comments [Not Specified]
Method Regression, Logistic
Comments [Not Specified]
Method of Estimation Estimation Parameter Odds Ratio (OR)
Estimated Value 1.57
Confidence Interval (2-Sided) 95%
0.77 to 3.21
Estimation Comments [Not Specified]
Time Frame Continuously throughout study intervention period of 6 months
Adverse Event Reporting Description [Not Specified]
 
Arm/Group Title Arm 1 Stroke Self Management and Risk Factor Program Attention Control Group
Hide Arm/Group Description

Patient Secondary Stroke Risk Factor Program including Stroke Self Management and Stroke Peer Support

Physician stroke guideline adherence: Provided clinicians with Secondary Stroke Prevention Guidelines/Posted near workstations for Discharge Planning and Provided Clinicians with Seminar on Motivational Interviewing and Goal Setting to Modify Patient Health Behaviors

Secondary Stroke Self-Management and Risk Factor Management: Provided Post Stroke Guidelines on Secondary Prevention to Clinicians Preparing Discharge Plans; Provided Secondary Stroke Self-Management and Stroke Peer Support to Veteran Patients with Stroke/TIA

Received Phone Calls from Staff to Control for Attention
All-Cause Mortality
Arm 1 Stroke Self Management and Risk Factor Program Attention Control Group
Affected / at Risk (%) Affected / at Risk (%)
Total   --/--   --/-- 
Hide Serious Adverse Events
Arm 1 Stroke Self Management and Risk Factor Program Attention Control Group
Affected / at Risk (%) Affected / at Risk (%)
Total   0/87 (0.00%)   0/87 (0.00%) 
Hide Other (Not Including Serious) Adverse Events
Frequency Threshold for Reporting Other Adverse Events 0%
Arm 1 Stroke Self Management and Risk Factor Program Attention Control Group
Affected / at Risk (%) Affected / at Risk (%)
Total   0/87 (0.00%)   0/87 (0.00%) 
Both our intervention and control groups experienced attrition during the study period but the rate between groups did not differ significantly.
Certain Agreements
All Principal Investigators ARE employed by the organization sponsoring the study.
Results Point of Contact
Layout table for Results Point of Contact information
Name/Title: Teresa Damush, Ph.D.
Organization: VA Stroke QUERI Center, Roudebush VAMC
Phone: 317-988-4277
EMail: Teresa.Damush@va.gov
Layout table for additonal information
Responsible Party: VA Office of Research and Development
ClinicalTrials.gov Identifier: NCT00355147    
Other Study ID Numbers: IAB 05-297
0608-01B ( Other Grant/Funding Number: US Veterans Health Administration )
1009001684 ( Other Grant/Funding Number: US Veterans Health Administration )
First Submitted: July 18, 2006
First Posted: July 21, 2006
Results First Submitted: July 15, 2014
Results First Posted: February 10, 2015
Last Update Posted: October 11, 2018